Warning letterPosted July 11, 2025
FDA warning letter to Alohma, LLC, d/b/a Kure CBD & Vape
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
FDA posted a warning letter to Alohma, LLC, d/b/a Kure CBD & Vape on July 11, 2025; the letter is dated July 10, 2025. Subject: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded. Issuing office: Center for Tobacco Products.
On the record
- Company
- Alohma, LLC, d/b/a Kure CBD & Vape
- Subject
- Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
- Issuing office
- Center for Tobacco Products
- Letter dated
- 2025-07-10
- Posted by FDA
- 2025-07-11
- Source
- FDA warning letters ↗
CFR cited
The record cites 1 section of 21 CFR Parts 1100, 1140 and 1141.
The full record
An account shows the violations FDA described and each CFR section it cited.
What a warning letter is
A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.
More
Watch Alohma, LLC, d/b/a Kure CBD & Vape
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA warning letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Alohma, LLC, d/b/a Kure CBD & Vape.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.